NDC 61841-055 - THERAFLEX Glucosamine Plus Max
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61841-055
- Package NDCs from labels
- 61841-055-12, 61841-055-60, 61841-055-30
- Manufacturer
- Bayer HealthCare LLC.
- Effective date
- 2026-01-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| THERAFLEX Glucosamine Plus Max Hard Gelatine Capsules | Bayer HealthCare LLC. | 2026-01-12 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61841-055-12 | THERAFLEX Glucosamine Plus Max | 1 in 1 CARTON | CAPSULE | 1 | 11 | |
| 61841-055-12 | THERAFLEX Glucosamine Plus Max | 120 in 1 BOTTLE | CAPSULE | 120 | 11 | |
| 61841-055-30 | THERAFLEX Glucosamine Plus Max | 1 in 1 CARTON | CAPSULE | 1 | 11 | |
| 61841-055-30 | THERAFLEX Glucosamine Plus Max | 30 in 1 BOTTLE | CAPSULE | 30 | 11 | |
| 61841-055-60 | THERAFLEX Glucosamine Plus Max | 1 in 1 CARTON | CAPSULE | 1 | 11 | |
| 61841-055-60 | THERAFLEX Glucosamine Plus Max | 60 in 1 BOTTLE | CAPSULE | 60 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CHONDROITIN SULFATE SODIUM (BOVINE) | ACTIVE INGREDIENT | 8QTV3DTT8W | THERAFLEX GLUCOSAMINE PLUS MAX (D-GLUCOSAMINE HYDROCHLORIDE, CHONDROITIN SULFATE SODIUM1) CAPSULE [BAYER HEALTHCARE LLC, CONSUMER CARE] | 1 | |
| CHONDROITIN SULFATE (BOVINE) | ACTIVE MOIETY | 6IC1M3OG5Z | THERAFLEX GLUCOSAMINE PLUS MAX (D-GLUCOSAMINE HYDROCHLORIDE, CHONDROITIN SULFATE SODIUM1) CAPSULE [BAYER HEALTHCARE LLC, CONSUMER CARE] | 1 | |
| MANGANESE SULFATE | INACTIVE INGREDIENT | W00LYS4T26 | THERAFLEX GLUCOSAMINE PLUS MAX (D-GLUCOSAMINE HYDROCHLORIDE, CHONDROITIN SULFATE SODIUM1) CAPSULE [BAYER HEALTHCARE LLC, CONSUMER CARE] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vitrexyl plus Iron | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ada43056-a3ce-e7de-e053-2a95a90aa046 | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| PureVit DualFe Plus | FERROUS FUMARATE, POLYSACCHARIDE IRON COMPLEX | PureTek Corporation | 71f63741-cad4-43b5-bb3e-c63a188d10a2 | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Vitrexyl | FOLIC ACID | PureTek Corporation | ae064a9e-daba-fa86-e053-2a95a90a16a7 | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Vitranol Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b81daf17-430b-6ba2-e053-2a95a90a768b | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Vitrexate | FOLIC ACID | PureTek Corporation | b34fee43-bea9-45b7-e053-2a95a90aad4d | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Vitrexate FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b3637def-a701-673a-e053-2995a90a02d5 | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Venexa | FOLIC ACID | PureTek Corporation | ba130779-cdfd-086d-e053-2a95a90a2590 | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Venexa FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ba142128-21c4-4204-e053-2a95a90ae0d7 | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Ventrixyl Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | c7a626ec-88ec-d899-e053-2a95a90ab0ba | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | W00LYS4T26 |
| Concept OB | VITAMIN MINERAL SUPPLEMENT | U.S. Pharmaceutical Corporation | 37992a25-68bd-4050-b936-596ddedc25a3 | 2022-11-08 | Warnings, Adverse reactions | W00LYS4T26 |
| Manganum Sulphuricum | MANGANUM SULPHURICUM | Hahnemann Laboratories, INC. | e939792e-f82a-2cc1-e053-2995a90aac88 | 2022-09-21 | W00LYS4T26 | |
| Multitrace -4 Pediatric | TRACE ELEMENTS 4 | American Regent, Inc. | 5ee6a685-3c35-467b-8d4d-79efdd0bfa8e | 2019-04-25 | Warnings, Adverse reactions | W00LYS4T26 |
| Multitrace-5 | TRACE ELEMENTS 5 | American Regent, Inc. | ef63bbe8-ebf8-436c-b38d-6cb92bc91ac0 | 2019-04-25 | Warnings, Adverse reactions | W00LYS4T26 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.